NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
+16.93%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$631M
AUM Growth
+$631M
(+18%)
Cap. Flow
+$31.9M
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
94.49%
Holding
13
New
2
Increased
3
Reduced
2
Closed
1
Top Buys
| 1 |
Tyra Biosciences
TYRA
|
$25.2M |
| 2 |
Relay Therapeutics
RLAY
|
$20.8M |
| 3 |
SLN
Silence Therapeutics
SLN
|
$20.6M |
| 4 |
BOLD
Boundless Bio
BOLD
|
$17.5M |
| 5 |
Oric Pharmaceuticals
ORIC
|
$13.8M |
Top Sells
| 1 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$44.6M |
| 2 |
Arvinas
ARVN
|
$11.9M |
| 3 |
Mersana Therapeutics
MRSN
|
$9.51M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $203M | 32.17% | 6,296,740 | – | – |
|
|
2
Oric Pharmaceuticals
ORIC
$994M
| $72.7M | 11.52% | 5,285,714 +1,000,000 | +23% | +$13.8M |
|
|
3
Tyra Biosciences
TYRA
$675M
| $66.5M | 10.54% | 4,055,861 +1,537,279 | +61% | +$25.2M |
|
|
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
| $59M | 9.35% | 2,642,502 | – | – |
|
|
5
Arvinas
ARVN
$568M
| $58.1M | 9.22% | 1,408,394 -287,251 | -17% | -$11.9M |
|
6
Tango Therapeutics
TNGX
$747M
| $43.9M | 6.97% | 5,533,980 | – | – |
|
|
7
Relay Therapeutics
RLAY
$619M
| $31.9M | 5.06% | 3,846,409 +2,500,000 | +186% | +$20.8M |
|
8
Cullinan Oncology
CGEM
$445M
| $20.8M | 3.3% | 1,221,145 | – | – |
|
|
SLN
9
Silence Therapeutics
SLN
$227M
| $20.6M | 3.26% | +952,400 | New | +$20.6M |
|
10
ARS Pharmaceuticals
SPRY
$1.15B
| $19.5M | 3.09% | 1,910,029 | – | – |
|
|
BOLD
11
Boundless Bio
BOLD
$25.1M
| $17.5M | 2.77% | +1,228,069 | New | +$17.5M |
|
|
12
Mersana Therapeutics
MRSN
$36.5M
| $17.3M | 2.74% | 3,856,321 -2,122,006 | -35% | -$9.51M |
|
|
AMAM
13
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| – | – | -3,129,300 | Closed | -$44.6M |
|